Evidence map›Paper›PMID 22039581›Full record

ArticleJournal of lipid research2012

Severe hepatocellular disease in mice lacking one or both CaaX prenyltransferases.

Shao H Yang, Sandy Y Chang, Yiping Tu, Gregory W Lawson, Martin O Bergo, Loren G Fong, Stephen G Young

Open access · hybridAbstract read
In one paragraph

Article in Journal of lipid research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Targeting protein prenylation in progeria.Science translational medicine · 2013
    Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Shao H YangDepartment of Medicine, University of California, Los Angeles, CA 90095, USA.
Sandy Y Chang
Yiping Tu
Gregory W Lawson
Martin O Bergo
Loren G Fong
Stephen G Young
University of California, Los Angeles · USUniversity of Gothenburg · SE

Funding

Refining Physiologic Mechanisms for Intravascular Triglyceride MetabolismR01HL087228 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BEIGNEUX, ANNE, FONG, LOREN GI · 2007 to 2024
$7.8M
Vascular Biology Training GrantT32HL069766 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LUSIS, ALDONS JAKE · 2002 to 2022
$7.4M
New Therapeutic Approaches for Hutchinson-Gilford Progeria SyndromeR01HL086683 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI FONG, LOREN GI · 2007 to 2011
$2.2M
CaaX Protein Processing and Human DiseaseR01AG035626 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI YOUNG, STEPHEN G. · 2009 to 2013
$2.0M
Protein Prenylation and ProgeriaR01HL089781 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI FONG, LOREN GI · 2009 to 2013
$1.9M
Hutchinson Gilford Progeria Syndrome and AtherosclerosisR01HL076839 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI YOUNG, STEPHEN G. · 2005 to 2009
$1.9M
CAAX Protein Processing and Cancer TherapyR01CA099506 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI YOUNG, STEPHEN G · 2003 to 2007
$1.7M
NCI NIH HHS CA-099506-07NCI NIH HHS R01 CA099506NHLBI NIH HHS HL-086683NHLBI NIH HHS HL-089781NHLBI NIH HHS HL-76839NHLBI NIH HHS R01 HL076839NHLBI NIH HHS R01 HL086683NHLBI NIH HHS R01 HL087228NHLBI NIH HHS R01 HL089781NHLBI NIH HHS T32 HL069766NIA NIH HHS R01 AG035626
6 · The paper itself

Abstract

Protein farnesyltransferase (FTase) and protein geranylgeranyltransferase-I (GGTase-I) add 15- or 20-carbon lipids, respectively, to proteins that terminate with a CaaX motif. These posttranslational modifications of proteins with lipids promote protein interactions with membrane surfaces in cells, but the in vivo importance of the CaaX prenyltransferases and the protein lipidation reactions they catalyze remain incompletely defined. One study concluded that a deficiency of FTase was inconsequential in adult mice and led to little or no tissue pathology. To assess the physiologic importance of the CaaX prenyltransferases, we used conditional knockout alleles and an albumin-Cre transgene to produce mice lacking FTase, GGTase-I, or both enzymes in hepatocytes. The hepatocyte-specific FTase knockout mice survived but exhibited hepatocellular disease and elevated transaminases. Mice lacking GGTase-I not only had elevated transaminases but also had dilated bile cannaliculi, hyperbilirubinemia, hepatosplenomegaly, and reduced survival. Of note, GGTase-I-deficient hepatocytes had a rounded shape and markedly reduced numbers of actin stress fibers. Hepatocyte-specific FTase/GGTase-I double-knockout mice closely resembled mice lacking GGTase-I alone, but the disease was slightly more severe. Our studies refute the notion that FTase is dispensable and demonstrate that GGTase-I is crucial for the vitality of hepatocytes.

Indexed as

Alkyl and Aryl TransferasesAnimalsDimethylallyltranstransferaseFarnesyltranstransferaseHepatocytesLiverLiver DiseasesMiceMice, KnockoutProtein PrenylationAlkyl and Aryl TransferasesDimethylallyltranstransferaseFarnesyltranstransferasegeranylgeranyltransferase type-I

Identifiers

PMID22039581
PMCPMC3243483
OpenAlexW2155699031

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.